Clinical Trials Directory

Trials / Unknown

UnknownNCT02772185

Neurostimulation and Cognitive Intervention in Alzheimer's Disease

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Federal University of Paraíba · Academic / Other
Sex
All
Age
60 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study is a double blind, sham-controlled clinical trial aiming to compare the long-term effects of stimulation in Alzheimer's Disease (AD). Sixty early AD patients will take part in a phase II/III clinical study over a 1-year period. The study involves transcranial direct current stimulation (tDCS), cognitive training (CT), detailed neuropsychological and neurological testing. These assessments will occur at baseline, then again at two month (end point). Those who achieve clinical improvement with neurostimulation and cognitive therapy will be invited to receive treatment for 12 months as part of a follow-up study.

Detailed description

The patients will be randomized into 1 of 4 groups: active tDCS plus real CT, active tDCS plus placebo CT, sham tDCS plus real CT, sham tDCS plus placebo CT. Each group will receive treatment for 30 minutes a day, 3 days a week for 8 weeks.

Conditions

Interventions

TypeNameDescription
DEVICEactive tDCSDuration: 30 minutes; Intensity: 2 mA; Placement:left and right parietal cortex, left and right DLPFC, left inferior frontal gyrus and left superior temporal gyrus
DEVICEsham tDCSThe procedure is the same as for active tDCS, but the in the placebo tDCS the stimulation is non-active / sham.
BEHAVIORALreal CTCognitive tasks designed to relate to the region of the brain being stimulated (left and right parietal cortex, left and right DLPFC, left inferior frontal gyrus and left superior temporal gyrus).
BEHAVIORALplacebo CTVideos (short films) will be presented during the neurostimulation

Timeline

Start date
2016-05-01
Primary completion
2018-05-01
Completion
2019-05-01
First posted
2016-05-13
Last updated
2016-05-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02772185. Inclusion in this directory is not an endorsement.